Sequenom Earnings: Here’s Why Investors are Buying Shares Now

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Sequenom Inc. (NASDAQ:SQNM) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 5.04%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Sequenom Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased to $-0.26 in the quarter versus EPS of $-0.22 in the year-earlier quarter.

Revenue: Rose 158.04% to $38.5 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Sequenom Inc. reported adjusted EPS loss of $0.26 per share. By that measure, the company missed the mean analyst estimate of $-0.24. It beat the average revenue estimate of $38.29 million.

Quoting Management: “We are pleased to see sequential improvements in volume, revenue and margin during the quarter, an indication of steady growth and sustained momentum in 2013,” said Paul V. Maier, Sequenom’s CFO. “As we complete the process of moving our billing and collections processes in-house, we anticipate even greater control in monitoring our payments from payors and improved workflows that will help us improve our collection cycle and reimbursement.”

Key Stats (on next page)…

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business